Results 11 to 20 of about 7,815 (117)

A moderate response to plasmapheresis in nephrogenic systemic fibrosis

open access: yesClinics and Practice, 2011
Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium ...
Pelin Ustuner   +3 more
doaj   +2 more sources

Gadolinio y fibrosis sistémica nefrogénica Gadolinium and nephrogenic systemic fibrosis

open access: yesRevista Argentina de Radiología, 2012
Inicialmente llamada dermopatía fibrosante nefrogénica, la fibrosis sistémica nefrogénica (FSN) está fuertemente ligada a la inyección endovenosa de medios de contraste -basados en gadolinio- en pacientes con insuficiencia renal.
Claudia Cejas, Cecilia Acuña
doaj   +1 more source

Nephrogenic Fibrosing Dermopathy [PDF]

open access: yes, 2009
An adult female patient on hemodialysis for chronic renal failure presented with large, brownish, and indurated plaques with bound-down skin on both lower limbs and abdomen along with difficulty in movement of the legs.
Ragunatha, S.   +4 more
core   +3 more sources

Nephrogenic systemic fibrosis

open access: yesIndian Dermatology Online Journal, 2011
Nephrogenic systemic fibrosis (NSF) is a relatively new fibrosing disorder which has caught the attention of various specialities in the past decade. NSF is an extremely disabling and often painful condition, affecting up to 13% of the individuals with ...
Bhushan Madke, Uday Khopkar
doaj   +1 more source

Nephrogenic Systemic Fibrosis Associated with Gadolinium Use

open access: yesJournal of the Formosan Medical Association, 2008
Nephrogenic systemic fibrosis (NSF) is an idiopathic, progressive, systemic fibrosis that occurs in patients with renal diseases. Recently, gadolinium-containing contrast (Gd-contrast) has become a suspected causal factor for NFS.
Chi-Chao Chao   +5 more
doaj   +1 more source

Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction

open access: yesInternational Brazilian Journal of Urology, 2015
Introduction/Objective: Ureteral obstruction is a common pathology and causes kidney fibrosis and dysfunction at late period. In this present study, we investigated the antifibrotic and antiinflammatory effects of hydrogen sulfide on kidney damage after ...
Murat Dursun   +8 more
doaj   +1 more source

European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis [PDF]

open access: yes, 2017
The term 'sclerosing diseases of the skin' comprises specific dermatological entities which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement ...
Kreuter, A   +43 more
core   +2 more sources

Manifestações cutâneas na doença renal terminal Cutaneous manifestations in end-stage renal disease

open access: yesAnais Brasileiros de Dermatologia, 2011
A prevalência da doença renal crônica aumentou nos últimos anos. Os efeitos dessa doença são complexos e podem levar à disfunção de múltiplos órgãos, entre eles, a pele. A maioria dos pacientes apresenta pelo menos uma alteração dermatológica.
Omar Lupi   +9 more
doaj   +1 more source

Nephrogenic systemic fibrosis: concepts and perspectives Fibrose nefrogênica sistêmica: conceitos e perspectivas

open access: yesAnais Brasileiros de Dermatologia, 2012
Nephrogenic systemic fibrosis is a chronic, progressive condition that develops in some patients with renal impairment after exposure to gadolinium-based contrast agents used in magnetic resonance imaging.
Ana Carolina de Souza Machado Igreja   +3 more
doaj   +1 more source

Gd‐EOB‐DTPA‐Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon’s Perspective!

open access: yesInternational Journal of Hepatology, Volume 2013, Issue 1, 2013., 2013
Colorectal cancer affects over one million people worldwide annually, with the liver being the most common site of metastatic spread. Adequate resection of hepatic metastases is the only chance for a cure in a subset of patients, and five‐year survival increases to 35% with complete resection.
Kelly J. Lafaro   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy